[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Drbagholders DrBagholder
DrBagholder posts on X about $sgmo, $novo, $embrac, $asmodee the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXXXX -XX%
- X Month XXXXX +1,683%
- X Months XXXXXX +21%
- X Year XXXXXX +1,858%
Mentions: X #
- X Month X +25%
- X Months XX +5.90%
- X Year XX +560%
Followers: XXX #
- X Week XXX +4.70%
- X Month XXX +10%
- X Months XXX +110%
- X Year XXX +84%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence stocks technology brands cryptocurrencies
Social topic influence $sgmo #15, $novo #2, $embrac, $asmodee, $acast, $hnsa, $googl, $ampx, $ntla, $mdxh
Top assets mentioned Alphabet Inc Class A (GOOGL) Intellia Therapeutics, Inc (NTLA) Sarepta Therapeutics, Inc. (SRPT) uniQure N.V. (QURE)
Top Social Posts #
Top posts by engagements in the last XX hours
"$EMBRAC Embracer Group $ASMODEE Asmodee $ACAST - Acast $HNSA - Hansa Biopharma"
X Link @Drbagholders 2025-10-07T17:29Z XXX followers, 1128 engagements
"💼 $GOOGL Google $AMPX Amprius Technologies $NTLA Intellia Therapeutics $MDXH MDxHealth $AIRO Airo Group $OSSD OssDsign $SGMO Sangamo Therapeutics $SRPT Sarepta Therapeutics $NKTR Nektar Therapeutics $MCLAIR Medclair $NOVO Novo Nordisk $BIOA BioArctic"
X Link @Drbagholders 2025-10-07T17:22Z XXX followers, 1290 engagements
"This years Nobel price in Physics goes to Sangamos management for bending the laws of market gravity by keeping the stock under $X despite stellar Fabry data in a raging bull market. Truly groundbreaking $SGMO"
X Link @Drbagholders 2025-10-07T09:50Z XXX followers, 4438 engagements
"$S sentinelone breakout"
X Link @Drbagholders 2025-09-18T14:13Z XXX followers, XXX engagements
"Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2025 World Muscle Society Congress"
X Link @Drbagholders 2025-10-04T11:18Z XXX followers, XXX engagements
"ST-503 (Nav1.7) Risk-Adjusted NPV Should be taken with a grain of salt but tells you something about the asymmetric upside in $SGMO"
X Link @Drbagholders 2025-10-12T09:42Z XXX followers, 1215 engagements
"$QURE (the bull thesis)"
X Link @Drbagholders 2025-10-11T10:01Z XXX followers, 1310 engagements
"Omeros Corporation - Novo Nordisk and Omeros announce asset purchase and license agreement for Omeros clinical-stage MASP-3 inhibitor zaltenibart (OMS906) $NOVO $OMER"
X Link @Drbagholders 2025-10-15T18:55Z XXX followers, XXX engagements